235 related articles for article (PubMed ID: 29096895)
1. Microbiota and Breast Cancer.
Mani S
Prog Mol Biol Transl Sci; 2017; 151():217-229. PubMed ID: 29096895
[TBL] [Abstract][Full Text] [Related]
2. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study.
Plaza-Díaz J; Álvarez-Mercado AI; Ruiz-Marín CM; Reina-Pérez I; Pérez-Alonso AJ; Sánchez-Andujar MB; Torné P; Gallart-Aragón T; Sánchez-Barrón MT; Reyes Lartategui S; García F; Chueca N; Moreno-Delgado A; Torres-Martínez K; Sáez-Lara MJ; Robles-Sánchez C; Fernández MF; Fontana L
BMC Cancer; 2019 May; 19(1):495. PubMed ID: 31126257
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer and Its Relationship with the Microbiota.
Fernández MF; Reina-Pérez I; Astorga JM; Rodríguez-Carrillo A; Plaza-Díaz J; Fontana L
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30110974
[TBL] [Abstract][Full Text] [Related]
4. Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored.
Mikó E; Kovács T; Sebő É; Tóth J; Csonka T; Ujlaki G; Sipos A; Szabó J; Méhes G; Bai P
Cells; 2019 Mar; 8(4):. PubMed ID: 30934972
[TBL] [Abstract][Full Text] [Related]
5. The Microbiome-Estrogen Connection and Breast Cancer Risk.
Parida S; Sharma D
Cells; 2019 Dec; 8(12):. PubMed ID: 31847455
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota homeostasis restoration may become a novel therapy for breast cancer.
Feng ZP; Xin HY; Zhang ZW; Liu CG; Yang Z; You H; Xin HW
Invest New Drugs; 2021 Jun; 39(3):871-878. PubMed ID: 33454868
[TBL] [Abstract][Full Text] [Related]
7. The microbiome and breast cancer: a review.
Chen J; Douglass J; Prasath V; Neace M; Atrchian S; Manjili MH; Shokouhi S; Habibi M
Breast Cancer Res Treat; 2019 Dec; 178(3):493-496. PubMed ID: 31456069
[TBL] [Abstract][Full Text] [Related]
8. The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.
Kwa M; Plottel CS; Blaser MJ; Adams S
J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27107051
[TBL] [Abstract][Full Text] [Related]
9. Association between the microbiota and women's cancers - Cause or consequences?
Alizadehmohajer N; Shojaeifar S; Nedaeinia R; Esparvarinha M; Mohammadi F; Ferns GA; Ghayour-Mobarhan M; Manian M; Balouchi A
Biomed Pharmacother; 2020 Jul; 127():110203. PubMed ID: 32559847
[TBL] [Abstract][Full Text] [Related]
10. The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease.
Hieken TJ; Chen J; Hoskin TL; Walther-Antonio M; Johnson S; Ramaker S; Xiao J; Radisky DC; Knutson KL; Kalari KR; Yao JZ; Baddour LM; Chia N; Degnim AC
Sci Rep; 2016 Aug; 6():30751. PubMed ID: 27485780
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Role of the Microbiota in Breast Cancer Progression.
Bernardo G; Le Noci V; Di Modica M; Montanari E; Triulzi T; Pupa SM; Tagliabue E; Sommariva M; Sfondrini L
Cells; 2023 Jul; 12(15):. PubMed ID: 37566024
[TBL] [Abstract][Full Text] [Related]
12. Microbial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights.
Parida S; Sharma D
Cells; 2020 Apr; 9(5):. PubMed ID: 32354130
[TBL] [Abstract][Full Text] [Related]
13. The Microbiota of Breast Tissue and Its Association with Breast Cancer.
Urbaniak C; Gloor GB; Brackstone M; Scott L; Tangney M; Reid G
Appl Environ Microbiol; 2016 Aug; 82(16):5039-48. PubMed ID: 27342554
[TBL] [Abstract][Full Text] [Related]
14. In-Silico Characterization of Estrogen Reactivating β-Glucuronidase Enzyme in GIT Associated Microbiota of Normal Human and Breast Cancer Patients.
Muccee F; Ghazanfar S; Ajmal W; Al-Zahrani M
Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140713
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications.
Yang J; Tan Q; Fu Q; Zhou Y; Hu Y; Tang S; Zhou Y; Zhang J; Qiu J; Lv Q
Breast Cancer; 2017 Mar; 24(2):220-228. PubMed ID: 27709424
[TBL] [Abstract][Full Text] [Related]
16. The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer.
Kovács T; Mikó E; Ujlaki G; Yousef H; Csontos V; Uray K; Bai P
Cancer Metastasis Rev; 2021 Dec; 40(4):1223-1249. PubMed ID: 34967927
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and breast cancer: may the microbiome be the issue?
Lasagna A; Zuccaro V; Ferraris E; Corbella M; Bruno R; Pedrazzoli P
Future Oncol; 2021 Jan; 17(2):123-126. PubMed ID: 33244989
[No Abstract] [Full Text] [Related]
18. Intestinal Proportion of Blautia sp. is Associated with Clinical Stage and Histoprognostic Grade in Patients with Early-Stage Breast Cancer.
Luu TH; Michel C; Bard JM; Dravet F; Nazih H; Bobin-Dubigeon C
Nutr Cancer; 2017; 69(2):267-275. PubMed ID: 28094541
[TBL] [Abstract][Full Text] [Related]
19. Chemical communication in the gut: Effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens.
Vogt SL; Peña-Díaz J; Finlay BB
Anaerobe; 2015 Aug; 34():106-15. PubMed ID: 25958185
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.
Bruner SD; Jobin C
Clin Pharmacol Ther; 2016 Jun; 99(6):585-7. PubMed ID: 26850686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
